- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Depression in Patients With Chronic Obstructive Pulmonary Disease in Canada
Total 403 results
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, Argentina, Germany, Spain, South Africa, Mexico, Peru, Netherlands, Canada, United Kingdom, Denmark, Chile, Italy, Sweden
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Australia, Germany, Estonia, Chile, Netherlands, Peru, South Africa, Sweden, Mexico, United Kingdom, Italy, Philippines, Canada
-
Laval UniversityRecruitingOxygen Deficiency | COPD ExacerbationCanada
-
SanofiTerminatedRespiratory Tract Infections | Pneumonia | Chronic BronchitisUnited States, Canada
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Austria, Belgium, Brazil, Canada, China, Colombia, Croatia, Germany, Hungary, India, Ireland, Japan, Norway, Romania, Russian Federation, Serbia, Slovakia, South Africa, Spain, Sweden, Taiwan, Turkey, United Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Spain, United States, United Kingdom
-
AstraZenecaCompletedLung Diseases | Pulmonary Disease | COPD | COPD Exacerbation | Respiratory Disorders | Chronic Obstructive Airway Disease | Chronic Obstructive Lung DiseasesUnited States, Argentina, Canada, Chile, Colombia, Italy, Malaysia, Mexico, Peru, Philippines, Romania, Russian Federation, Serbia, Spain, Taiwan, Thailand, Ukraine
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveNetherlands, Belgium, United States
-
AstraZenecaTerminatedPulmonary Disease, Chronic ObstructiveUnited States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada, Germany, Hungary, Korea, Republic of, Mexico, Poland, Russian Federation, Spain, Taiwan
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Japan, Poland, Romania, Russian Federation, Spain, Ukraine, Germany, Taiwan, Bulgaria, Hungary, France, Philippines, South Africa, Thailand, Israel, Korea, Republic of, Australia, Mexico, Slovakia, United... and more
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, Colombia, Croatia, Czechia, Denmark, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, India, Ireland, Italy, Japan, Korea, Republic of, Latv... and more
-
PfizerTerminatedPulmonary Disease, Chronic ObstructiveAustralia, Canada, Czech Republic, Croatia, Spain, Hungary, Argentina, Singapore, United Kingdom, Chile
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Estonia, Canada, Chile, Germany, Peru, Philippines, Mexico, Korea, Republic of, Denmark, Russian Federation, Poland, Slovakia
-
Universidad de GranadaUnknown
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Spain, Netherlands, Canada
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Australia, United States, Germany, Chile, Korea, Republic of, Mexico, Canada, South Africa, Romania
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustria, Germany, Canada, United States, Poland, Belgium, Portugal, United Kingdom, Australia, Denmark, New Zealand
-
Umeå UniversityRadboud University Medical Center; Centre de Recherche de l'Institut Universitaire... and other collaboratorsCompletedPulmonary Disease | Chronic ObstructiveSweden, Canada, Netherlands
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveBelgium, Canada, Netherlands, Germany
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, Canada, France, Poland, Russian Federation, Spain, Estonia, Belgium, Peru, Sweden, Greece, Mexico, Norway, Italy, Czechia
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Austria, Canada, Germany, Netherlands, Russian Federation, Sweden
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveGermany, Canada, Spain, Russian Federation, United States, Belgium, France, Greece, Sweden, Norway, Turkey, Australia, Netherlands, United Kingdom
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada, Germany
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Germany, Japan, Romania, Ukraine, Chile, Korea, Republic of, Taiwan, Netherlands, United Kingdom, Canada, Denmark, Australia, Slovakia
-
Boehringer IngelheimTerminatedPulmonary Disease, Chronic ObstructiveUnited States, Austria, Belgium, Canada, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, Slovakia, Sweden
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveJapan
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic Obstructive | Pulmonary EmphysemaUnited States, Spain, Denmark, Belgium, Korea, Republic of, Canada, Germany, United Kingdom, Sweden, Finland, Japan, Poland
-
NovartisCompletedLung Diseases, Obstructive | Pulmonary Disease, Chronic Obstructive | COPDUnited States, Germany, Spain, Argentina, Italy, Turkey, Canada, India, Sweden, Korea, Republic of, Taiwan, Puerto Rico
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Australia, Austria, Belgium, Canada, Chile, Germany, Italy, New Zealand
-
CSA Medical, Inc.CompletedBronchitis, Chronic | Cryotherapy EffectNetherlands, Canada, United Kingdom
-
McMaster UniversityCompletedCoronary Artery Disease | Stroke | Multiple Sclerosis | Hypertension | Diabetes | Chronic Obstructive Pulmonary Disease | Osteoarthritis | Rheumatoid Arthritis | Back Pain | OsteoporosisCanada
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada, Ukraine, Spain, United Kingdom, New Zealand, Netherlands, Bulgaria, Norway, Denmark, Czech Republic, Slovenia
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Canada, Finland, France, Germany, Hungary, Italy, Spain, United Kingdom
-
AstraZenecaCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada
-
CABYCBayer; Genzyme, a Sanofi Company; Fundacion Clinic per a la Recerca Biomédica; Grupo... and other collaboratorsWithdrawnChronic Lymphocytic Leukaemia | Patients Resistant to a Purine Analogous | Patients Relapsed With Purines TherapySpain
-
Daren K. HeylandCanadian Institutes of Health Research (CIHR)CompletedCancer | Critical Illness | Cirrhosis | Congestive Heart Failure | Chronic Obstructive Lung DiseaseCanada
-
Boston Scientific CorporationPneumRx, Inc.TerminatedEmphysemaUnited States, Netherlands, France, Canada, United Kingdom
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, China, Germany, Taiwan
-
Brigham and Women's HospitalThe Thompson Family Foundation IncCompletedHeart Failure | Infections | Chronic Kidney Diseases | Chronic Obstructive Pulmonary Disease | Asthma | Anticoagulation | Gout Flare | Hypertensive Urgency | Atrial Fibrillation Rapid | Diabetes and Its Complications | End of Life/Desires Only Medical ManagementUnited States, Canada
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveSpain
-
Boston Scientific CorporationPneumRx, Inc.TerminatedEmphysemaUnited States, Netherlands, France, Canada, Germany, United Kingdom
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustria, Canada, Spain, United States, Finland, Italy, Russian Federation, United Kingdom, New Zealand, Australia, France, Greece, Ireland, Netherlands, South Africa
-
Astellas Pharma Europe B.V.FibroGenCompletedAnemia in Chronic Kidney Disease in Non-dialysis PatientsSpain, Belarus, Bulgaria, Hungary, Poland, Romania, Russian Federation, Serbia, Ukraine, United Kingdom, Belgium, Georgia, Italy, Colombia, Dominican Republic, Estonia, Greece, Guatemala, Panama, Peru, South Africa, Turkey
-
Spiration, Inc.CompletedEmphysemaUnited States, Canada
-
PfizerTerminatedAvelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid TumorsUnited States, Canada, United Kingdom, Korea, Republic of, Australia, Belgium, Denmark, Hungary, Russian Federation
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Broncus TechnologiesUnknownEmphysemaUnited States, Spain, Australia, Canada, Ireland, United Kingdom, Austria, Brazil, Germany, Netherlands
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveCanada, Germany, United States, Australia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveJapan, Russian Federation, Spain, United States, Bulgaria, Canada, Poland, South Africa, Thailand, Mexico, Chile, Greece, Czechia